Internal Medicine, Hematology & Oncology · New York, NY
NPI
1881842722
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
178 E 85th St, 4th Floor
New York, NY, 10028
Phone (212) 434-3630
Groups this clinician bills Medicare through
Medicare paid, 2024
$140K
1,762 services
Medicare patients, 2024
270
Average age 76
Drug cost, 2024
$2.1M
550 prescriptions
Company payments, 2025
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin M Sullivan was code 99214 (office e&m - established), 664 times for 129 patients. In total Kevin M Sullivan billed 1,762 services in 17 codes, and Medicare paid $140K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 664 | 129 | $109.22 | $73K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 551 | 166 | $14.56 | $8,020 |
| 99215 Office E&M - Established | Office | 134 | 74 | $156.76 | $21K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 108 | 53 | $29.15 | $3,149 |
| 99213 Office E&M - Established | Office | 99 | 65 | $79.04 | $7,825 |
| 99223 Hospital E&M - Initial | Facility | 54 | 52 | $153.51 | $8,290 |
| 99205 Office E&M - New | Office | 50 | 50 | $201.16 | $10K |
| 99233 Hospital E&M - Subsequent | Facility | 39 | 26 | $104.69 | $4,083 |
| 99214 Office E&M - Established | Facility | 18 | 12 | $84.63 | $1,523 |
By year: 2022 $118K for 1,011 services; 2023 $121K for 1,105 services; 2024 $140K for 1,762 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin M Sullivan prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 65 prescriptions and refills. In total Kevin M Sullivan wrote 550 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 65 | 65 | 17 | $1.1M |
| Metoclopramide Hcl Generic | 53 | 53 | 41 | $214 |
| Dexamethasone Generic | 48 | 48 | 31 | $625 |
| Eliquis Apixaban | 40 | 46 | Under 11 | $26K |
| Folic Acid Generic | 28 | 35 | Under 11 | $92.67 |
| Gilotrif Afatinib Dimaleate | 27 | 27 | Under 11 | $312K |
| Famotidine Generic | 18 | 32 | Under 11 | $66.75 |
| Erlotinib Hcl Generic | 16 | 16 | Under 11 | $92K |
| Omeprazole Generic | 16 | 28 | Under 11 | $97.24 |
| Lumakras Sotorasib | 13 | 13 | Under 11 | $170K |
| Levothyroxine Sodium Generic | 13 | 13 | Under 11 | $48.97 |
| Clindamycin Phosphate Generic | 12 | 12 | Under 11 | $526 |
| Oxycodone Hcl Generic | 11 | 11 | Under 11 | $75.76 |
Brand drugs: 172 claims; generic drugs: 378 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin M Sullivan $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.